ADC Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Oaktree Fund Administration, LLC(5.19%),Oaktree Capital Holdings, LLC(5.19%), etc.
May 4 09:37
ADC Therapeutics | DEF 14A: Definitive information statements
Apr 27 04:34
ADC Therapeutics | DEFA14A: Others
Apr 27 04:26
ADC Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-A.T. Holdings II Sarl(2.7%),C.T. Phinco Sarl(2.7%), etc.
Apr 26 04:16
ADC Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 17 04:22
ADC Therapeutics | 8-K: Current report
Apr 10 04:12
ADC Therapeutics | 424B3: Prospectus
Mar 16 04:18
ADC Therapeutics | 424B3: Prospectus
Mar 16 04:17
ADC Therapeutics | EFFECT: Others
Mar 15 18:35
ADC Therapeutics | EFFECT: Others
Mar 15 18:25
ADC Therapeutics | EFFECT: Others
Mar 15 18:20
ADC Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Mar 14 04:23
ADC Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Mar 14 04:21
ADC Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Mar 14 04:20
ADC Therapeutics | ARS: Annual Report to Security Holders
Mar 14 03:24
ADC Therapeutics | 10-K: Annual report
Mar 14 00:28
ADC Therapeutics | 8-K: ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
Mar 13 19:43
ADC Therapeutics | 8-K: Current report
Mar 5 22:17
ADC Therapeutics | 8-K: Current report
Mar 1 05:34
ADC Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(18.8%),Jeremy C. Green(18.8%), etc.
Feb 15 05:29
No Data
No Data